Liquid Biopsy
News and reporting on cell-free DNA testing.
Lucence Publishes Clinical Validation of LiquidHallmark Circulating Tumor DNA Test, Expands to RNA
Premium
The firm plans to ramp up US commercialization following the study, while continuing to develop its cell-free RNA diagnostic platform.
The company recently signed on Heska for selling its Nu.Q Vet Cancer Screening Test at the point of care, and Sage Healthcare as a distributor in Singapore.
Delfi Diagnostics, Memorial Sloan Kettering Partner to Advance Cancer Screening Technology
The partners' first project is an expansion of Delfi's previously announced prospective study of its blood-based screening assay in patients with a high risk of lung cancer.
Mirvie Raises $60M in Series B Funding
The company plans to use the funding to propel the clinical and commercial development of its Mirvie RNA testing platform for pregnancy health.
Intermountain Healthcare Rolling Out Galleri Multi-Cancer Early Detection Test in Pilot Program
Premium
The test is first available to employees over age 50 covered under Intermountain's SelectHealth, but the health system has a bigger five-year plan.